Curated News
By: NewsRamp Editorial Staff
March 13, 2025
Canada Royal Enoch's Redsenol-1 Plus Listed in NCI Drug Dictionary for Cancer Research Advancement
Discuss on Reddit
Substack
Telegram
GithubTLDR
- Redsenol-1 Plus's unique rare ginsenosides give it an advantage over conventional ginseng supplements, making it a standout in the market.
- Redsenol-1 Plus is defined in the NCI Drug Dictionary as an oral herbal supplement with sixteen rare ginsenosides derived from ginseng.
- Redsenol-1 Plus's potential in oncology and supportive care showcases Canada Royal Enoch Phytomedicine's commitment to advancing cancer research.
- Redsenol-1 Plus features highly bioactive and absorbable rare ginsenosides, setting it apart in the ginseng supplement industry.
Impact - Why it Matters
This news matters as it signifies a significant breakthrough in cancer research with the inclusion of Redsenol-1 Plus in a prestigious database. The unique rare ginsenosides in the supplement could potentially revolutionize cancer treatment and supportive care, offering hope to patients worldwide.
Summary
Canada Royal Enoch Phytomedicine announces that its Redsenol-1 Plus Noble Ginsenosides supplement is now listed in the National Cancer Institute's Drug Dictionary, highlighting its potential in oncology. This milestone showcases the company's commitment to cancer research and rare ginsenoside innovation.
Source Statement
This curated news summary relied on this press release disributed by 24-7 Press Release. Read the source press release here, Canada Royal Enoch's Redsenol-1 Plus Listed in NCI Drug Dictionary for Cancer Research Advancement
